Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT07489573 · RECRUITING
Trial details
- NCT number
- NCT07489573
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-09-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.